With Every Patient
At WEP Clinical, we are With Every Patient, as we believe every patient should have access to treatment!
With this as our guiding principle, we operate as a Pharmaceutical Services Provider that partners with pharma and biotech companies and CROs to create broader treatment access solutions for patients worldwide.
We specialize in the following: Non-Interventional Trials (Open Label Extensions, Long Term Safety Follow-Up Studies, Registries); Expanded Access and Post-Approval Named Patient Programs; Market Access and Commercialization; and Strategic Decentralized Nursing Solutions.
Our Mission
To connect Sponsors, patients and key industry stakeholders to create broader treatment access solutions for patients worldwide.
Our Experience
We have been providing access programs to make much-needed medicines available to patients since 2008.
Our Core Services
The services we offer provide access to treatment for patients both in and out of clinical trials and add value for Sponsors at all stages across the drug development, approval and commercialization processes.
WEP Milestones
WE Pharma Incorporated is set up in London, UK
We began to supply reference products to generic manufacturers
First Supply of Unlicensed Medicines
Our first supply of unlicensed medicines were delivered to Healthcare Professionals in Europe
Post-Approval Named Patient Programs
Company begins supplying product to patients through a PA-NPP
We Opened US Office
US office opens in North Carolina, to support our growing global reach
First Early Access Program
Company begins supplying products to patients through its first formal EAP
WEP Clinical
WE Pharma now trades under the name WEP Clinical
We Are Expanding
Product commercialization activities begin in France, Germany, Italy, Spain and the United Kingdom (EU5)
Wren Healthcare Becomes Part of the WEP Clinical
Wren Healthcare becomes part of the WEP Clinical family allowing us to provide Home Nursing Services for Decentralized Clinical Trials
Investment Made by The Jordan Company
Investment made by The Jordan Company to help navigate WEP Clinical through its next phase of growth